ARENACCIO, CLAUDIA
 Distribuzione geografica
Continente #
NA - Nord America 1557
EU - Europa 501
AS - Asia 209
AF - Africa 2
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2272
Nazione #
US - Stati Uniti d'America 1556
CN - Cina 165
GB - Regno Unito 145
SE - Svezia 120
DE - Germania 74
IE - Irlanda 33
UA - Ucraina 31
IT - Italia 29
VN - Vietnam 26
DK - Danimarca 18
RU - Federazione Russa 18
TR - Turchia 17
AL - Albania 12
FI - Finlandia 12
NL - Olanda 3
AU - Australia 2
FR - Francia 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
CA - Canada 1
EE - Estonia 1
IN - India 1
ME - Montenegro 1
RO - Romania 1
Totale 2272
Città #
Fairfield 286
Woodbridge 245
Chandler 146
Southend 138
Houston 128
Ashburn 125
Wilmington 100
Seattle 99
Cambridge 98
Ann Arbor 63
Dearborn 49
Nanjing 37
Jacksonville 34
Dublin 31
Princeton 29
Dong Ket 26
Redwood City 18
Shenyang 18
Izmir 17
Beijing 13
Jinan 13
Hebei 12
San Diego 12
Changsha 11
Plano 10
Rome 10
Jiaxing 9
Kunming 9
Nanchang 8
Boardman 7
Tianjin 6
Böblingen 5
Guangzhou 5
Falls Church 4
Haikou 4
Bremen 3
Flushing 3
Fort Worth 3
Hangzhou 3
San Paolo di Civitate 3
Taizhou 3
Zhengzhou 3
Altamura 2
Auburn Hills 2
Dakar 2
Hefei 2
Lanzhou 2
London 2
Mentana 2
Milan 2
Mountain View 2
Nagold 2
Norwalk 2
Taiyuan 2
Trento 2
Bari 1
Bethesda 1
Buffalo 1
Cupertino 1
Dallas 1
Edinburgh 1
Greenwich 1
Groningen 1
Hanover 1
Mumbai 1
Nanning 1
Naples 1
New York 1
Ningbo 1
North York 1
Orange 1
Paris 1
Podgorica 1
Redmond 1
Tallinn 1
Timisoara 1
Verona 1
Totale 1894
Nome #
Exosomes from human immunodeficiency virus type 1 (HIV-1)-infected cells license quiescent CD4+ T lymphocytes to replicate HIV-1 through a Nef- and ADAM17-dependent mechanism. 186
The ADAR1 editing enzyme is encapsidated into HIV-1 virions 167
MiR-146a controls CXCR4 expression in a pathway that involves PLZF and can be used to inhibit HIV-1 infection of CD4+ T lymphocytes 157
The CD8⁺ T Cell-Mediated Immunity Induced by HPV-E6 Uploaded in Engineered Exosomes Is Improved by ISCOMATRIX(TM) Adjuvant 151
HIV-1 Nef Impairs Key Functional Activities in Human Macrophages through CD36 Downregulation 146
HIV-1-infected cells transiently express lentiviral RNA shuttled by exosomes 144
The Contribution of Extracellular Nef to HIV-Induced Pathogenesis 138
Uncovering the role of defective HIV-1 in spreading viral infection 138
Latent HIV-1 is activated by exosomes from cells infected with either replication-competent or defective HIV-1 125
HPV-E7 delivered by engineered exosomes elicits a protective CD8+ T cell-mediated immune response 123
Surface-bound Tat inhibits antigen-specific CD8(+) T-cell activation in an integrin-dependent manner 121
Cell activation and HIV-1 replication in unstimulated CD4+ T lymphocytes ingesting exosomes from cells expressing defective HIV-1 118
The intracellular delivery of anti-HPV16 E7 scFvs through engineered extracellular vesicles inhibits the proliferation of HPV-infected cells 92
DNA Vectors Generating Engineered Exosomes Potential CTL Vaccine Candidates Against AIDS, Hepatitis B, and Tumors 64
Trans-dissemination of exosomes from HIV-1-infected cells fosters both HIV-1 trans-infection in resting CD4+ T lymphocytes and reactivation of the HIV-1 reservoir 58
Antitumor HPV E7-specific CTL activity elicited by in vivo engineered exosomes produced through DNA inoculation 56
Engineered exosomes emerging from muscle cells break immune tolerance to HER2 in transgenic mice and induce antigen-specific CTLs upon challenge by human dendritic cells 48
Exosomes in Therapy: Engineering, Pharmacokinetics and Future Applications 46
HIV‐1 Nef Protein Affects Cytokine and Extracellular Vesicles Production in the GEN2.2 Plasmacytoid Dendritic Cell Line 46
Extracellular vesicle-mediated intercellular communication in HIV-1 infection and its role in the reservoir maintenance 45
N-terminal fatty acids of NEFmut are required for the CD8+ t-cell immunogenicity of in vivo engineered extracellular vesicles 36
An Exosome-Based Vaccine Platform Imparts Cytotoxic T Lymphocyte Immunity Against Viral Antigens 35
Development of a novel human phage display-derived anti-LAG3 scFv antibody targeting CD8+ T lymphocyte exhaustion 34
Tumor cells endowed with professional antigen-presenting cell functions prime PBLs to generate antitumor CTLs 29
Totale 2303
Categoria #
all - tutte 4896
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4896


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20182 0000 00 00 0011
2018/2019303 46113 3413 1912 0279876
2019/2020596 94301752 6368 6955 95201122
2020/2021559 18212718 17357 5063 12471063
2021/2022242 110300 4818 817 25132943
2022/2023373 41921643 3770 224 36390
Totale 2303